Print

Accelovance Named 2010 BEST CRO; Repeat Recognition for Vaccine Excellence  
4/27/2010 9:54:01 AM

ROCKVILLE, Md., April 27 /PRNewswire/ -- Accelovance, a privately held vaccine-focused clinical research company, enthusiastically announced today that it has been named the "Best Contract Research Organization" (CRO) at the 2010 World Vaccine Congress, held in Chantilly, VA last week. This is the second consecutive year Accelovance has received this prestigious honor.
//-->